PRNewsWire · October 23, 2026

Pathalys Pharma Presents Positive Data from Pivotal Phase 3 Studies of Upacicalcet in Featured Oral Presentation at ASN Kidney Week 2026

Get the app for more

Explore stock news, insights and company research.